AdvaMed Begets "AdvaMed Dx" For IVD-Focused Lobbying Effort
This article was originally published in The Gray Sheet
Executive Summary
AdvaMed is forming an "association within an association" to focus exclusively on in vitro diagnostics, the group announced Dec. 17
You may also be interested in...
AdvaMedDx’s New Chairman Is BD Exec Vince Forlenza
Becton Dickinson President Vince Forlenza is the new chairman of AdvaMedDx, the division of the Advanced Medical Technology Association focused on in vitro diagnostics, the group announced Oct. 20 at the AdvaMed 2010 conference in Washington, D.C.
AdvaMedDx’s New Chairman Is BD Exec Vince Forlenza
Becton Dickinson President Vince Forlenza is the new chairman of AdvaMedDx, the division of the Advanced Medical Technology Association focused on in vitro diagnostics, the group announced Oct. 20 at the AdvaMed 2010 conference in Washington, D.C.
AdvaMed Dx
Diagnostics firms bioMerieux, Gen-Probe and Quidel recently joined AdvaMed's newly formed in-vitro-diagnostics-focused AdvaMed Dx division (1"The Gray Sheet" Dec. 21, 2009). Each of the companies had been in AdavMed at one time, but had let their memberships lapse